Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1993-03-22
1995-01-31
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
424 9463, 435226, C12N 948, A61K 32547
Patent
active
053857321
ABSTRACT:
A fibrinolytically active amino acid sequence variant of a plasminogen activator is prepared that has one or more glycosylation sites in regions that are not glycosylated in the native molecule. DNA sequences can be prepared that encode the variants, as well as expression vectors incorporating the DNA sequences, and host cells transformed with the expression vectors. The variants may be used in a pharmaceutical preparation to treat a vascular disease or condition in patients.
REFERENCES:
patent: 4766075 (1988-08-01), Goeddel et al.
patent: 5041376 (1991-08-01), Gething et al.
Gunzler, W. et al., "The Primary Structure of High Molecular Mass Urokinas from Human Urine The Complete Amino Acid Sequence of the A Chain," Hoppe-Seyler's Z. Physiol. Chem. Bd. 363: S. 1155-1165 (1982).
Holmes, W., et al., "Cloning and Expression of the Gene for Pro-Urokinase in Escherichia Coli," Bio/Technology 3: 923-929 (1985).
Kasai, S. et al., "Proteolytic Cleavage of Single-chain Pro-urokinase Induces Conformational Change which Follows Activation of the Zymogen and Reduction of Its High Affinity for Fibrin," J. Biol. Chem. 260(22): 12377-12381 (1985).
Kasai, S. et al., "Thrombolytic Properties of an Inactive Proenzyme Form of Human Urokinase Secreted from Human Kidney Cells," Cell Structure and Function 10: 151-159 (1985).
Pennica, D. et al., "Cloning and Expression of Human Tissue-type Plasminogen Activator cDNA in E. coli," Nature 301: 214-221 (1983).
Rijken and Collen, "Purification and Characterization of the Plasminogen Activator Secreted by Human Melanoma Cells in Culture," J. Biol. Chem. 256(13): 7035-7041 (1981).
Steffens, G. et al., "The Complete Amino Acid Sequence of Low Molecular Mass Urokinas from Human Urine," Hoppe-Seyler's Z. Physiol. Chem. Bd. 363: S. 1043-1058 (1982).
Pharmacia Fine Chemicals Catalogue 84, pp. 1 and 6.
Kaufman et al., Gene Amplification, 245-250, Cold Spring Harbor Laboratory (1982).
Ny et al., DNA, 7(10): 671-677 (1988).
Rickles et al., J. Biol. Chem., 263(3): 1563-1569 (1988).
Gardell et al., J. Biol. Chem., 264(30): 17947-17952 (1989).
Machamer & Rose, J. Biol. Chem., 263(12): 5948-5954 (1988).
Machamer & Rose, J. Biol. Chem., 263(12): 5955-5960 (1988).
Browne et al., J. Biol. Chem., 263(4): 1599-1602 (1988).
Harris, Protein Engineering, 1(6): 449-458 (1987).
Berman & Lasky, Trends in Biotechn. 3(2): 51-53 (1985).
Anderson Stephen
Brady Kevin M.
Keyt Bruce A.
Presta Leonard G.
Allen Marianne Porta
Draper Garnette D.
Dreger Ginger R.
Genentech Inc.
LandOfFree
Variants of tissue plasminogen activator, compositions and metho does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Variants of tissue plasminogen activator, compositions and metho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Variants of tissue plasminogen activator, compositions and metho will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1101194